scholarly journals Splenic Injury with Subsequent Pleural Effusion: An Underreported Complication of Colonoscopy

2019 ◽  
Vol 13 (1) ◽  
pp. 6-11 ◽  
Author(s):  
Idrees Suliman ◽  
John Guirguis ◽  
Iryna Chyshkevych ◽  
Nemer F. Dabage

Colorectal cancer is a leading cause of morbidity and mortality worldwide. As such, there are recognized guidelines in the screening of this preventable cancer. There are differences in opinion regarding screening recommendations between the European and United States Cancer Prevention Societies. Screening colonoscopy is an option for routine screening for colorectal cancer in asymptomatic adults. It is a day procedure that is conducted both in hospital and specialized outpatient endoscopy suites. Serious harm is in the region of 3 per 1,000 examinations [Am J Gastroenterol. 2016 Aug; 111(8): 1092–101]. Splenic injury is a rare complication of colonoscopy whose frequency is unclear. Conservative management of splenic injury is desirable in order to preserve immunocompetence. We present a case in which a previously healthy 59-year-old female developed a splenic injury and later pleural effusion after screening colonoscopy.

2019 ◽  
Vol 114 (1) ◽  
pp. S170-S170
Author(s):  
Ephraim S. Casper ◽  
Sita Chokhavatia ◽  
Haleh Pazwash ◽  
Sobeida Santana-Joseph ◽  
Leslie Ringelstein ◽  
...  

2006 ◽  
Vol 30 (2) ◽  
pp. 134-143 ◽  
Author(s):  
Ashar Ata ◽  
Jared D. Elzey ◽  
Tabassum Z. Insaf ◽  
Ana M. Grau ◽  
Steven C. Stain ◽  
...  

2009 ◽  
Vol 21 (6) ◽  
pp. 650-655 ◽  
Author(s):  
Bernd Bokemeyer ◽  
Herbert Bock ◽  
Dietrich Hüppe ◽  
Marc Düffelmeyer ◽  
Axel Rambow ◽  
...  

2008 ◽  
Vol 134 (4) ◽  
pp. A-162
Author(s):  
Bernd Bokemeyer ◽  
Axel Rambow ◽  
Dietrich Hüppe ◽  
Marc Düffelmeyer ◽  
Wolfgang Tacke ◽  
...  

2013 ◽  
Vol 31 (15_suppl) ◽  
pp. 1522-1522
Author(s):  
Daniel X Yang ◽  
Cary Philip Gross ◽  
James B. Yu

1522 Background: Ideally, screening detects cancer at a more curable stage, and as a result decreases the incidence of subsequent diagnosis at a late stage. Whereas breast cancer screening is suggested to have led to a substantial increase in the number of early-stage cancers diagnosed in the United States with only marginal reductions in the number of late stage cancers, the impact of colorectal cancer screening on cancer incidence is unknown. Methods: Colorectal cancer incidence data spanning over three decades, 1976—2009, were collected from the Surveillance, Epidemiology, and End Result (SEER) database. Screening utilization data spanning 1986—2010 were collected from the National Health Survey (NHS) progress reports. We examined trends in the incidence of early-stage (in situ, local) and late-stage (regional, distant) colorectal cancer among adults 50 years or older. Results: Over the past three decades, the incidence of late-stage colorectal cancer decreased significantly, from 118 to 74 cases per 100,000 people—a 37% decrease. The incidence of early-stage colorectal cancer also decreased, from 77 to 67 cases per 100,000 people. There was also an associated increase in the utilization rates of screening colonoscopy. From 1987 to 2010—the years for which NHS data were available—the percentage of adults 50 and older who received screening colonoscopy rose from 27% to 63%. After adjusting for trends in cancer incidence in non-screened populations, we estimated that colorectal screening was associated with a reduction of approximately 550,000 cases of colorectal cancer over the past three decades in the United States. Using the most conservative assumption of constant cancer incidence during the past three decades, 235,000 cases of colorectal cancer were prevented. Conclusions: There has been a significant decline in both early and late stage colorectal cancer diagnoses, during a time of increasing rates of increased screening.


Sign in / Sign up

Export Citation Format

Share Document